1. Home
  2. BWEN vs NXTC Comparison

BWEN vs NXTC Comparison

Compare BWEN & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$2.53

Market Cap

51.0M

Sector

Industrials

ML Signal

HOLD

Logo NextCure Inc.

NXTC

NextCure Inc.

HOLD

Current Price

$12.49

Market Cap

44.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
NXTC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
44.6M
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
BWEN
NXTC
Price
$2.53
$12.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$23.00
AVG Volume (30 Days)
243.5K
23.6K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.56
EPS
0.27
N/A
Revenue
$146,785,000.00
$22,378,000.00
Revenue This Year
$11.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.23
52 Week High
$4.15
$15.74

Technical Indicators

Market Signals
Indicator
BWEN
NXTC
Relative Strength Index (RSI) 44.13 53.88
Support Level $1.87 $10.77
Resistance Level $2.78 $13.47
Average True Range (ATR) 0.14 1.12
MACD 0.04 0.01
Stochastic Oscillator 57.32 60.57

Price Performance

Historical Comparison
BWEN
NXTC

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: